Bradley Foster & Sargent’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Hold
7,769
0.03% 230
2026
Q1
$2.07M Hold
7,769
0.03% 220
2025
Q4
$1.95M Hold
7,769
0.03% 229
2025
Q3
$2.23M Sell
7,769
-196
-2% -$52.5K 0.03% 210
2025
Q2
$2.09M Sell
7,965
-28
-0.4% -$6.82K 0.03% 213
2025
Q1
$1.86M Hold
7,993
0.03% 208
2024
Q4
$1.83M Buy
7,993
+1,000
+14% +$229K 0.03% 215
2024
Q3
$1.56M Buy
+6,993
New +$1.54M 0.03% 232
2024
Q1
Sell
-22,189
Closed -$5.04M 446
2023
Q4
$5.04M Sell
22,189
-7,367
-25% -$1.55M 0.1% 142
2023
Q3
$7.13M Sell
29,556
-4,847
-14% -$1.02M 0.15% 110
2023
Q2
$7.13M Buy
+34,403
New +$6.67M 0.15% 110

Other funds holding LH

Bradley Foster & Sargent's LH Position: Q2 2026 in Review

Bradley Foster & Sargent held its Labcorp (LH) position steady in Q2 2026 at 7,769 shares worth $2.18M. The position accounts for 0.03% of the portfolio, ranked #230.

Bradley Foster & Sargent first reported a position in LH in Q2 2023 and has held it in 11 quarters since. The position peaked at $7.13M in Q3 2023. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Bradley Foster & Sargent held 7,769 shares of Labcorp worth $2.18M as of Q2 2026.
  • Bradley Foster & Sargent left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.03% of Bradley Foster & Sargent's portfolio in Q2 2026, its #230 holding.
  • Bradley Foster & Sargent first reported a position in Labcorp in Q2 2023 and has held it in 11 quarters since.
  • Bradley Foster & Sargent's Labcorp position peaked at $7.13M in Q3 2023.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.